All Posts Tagged With: "INHX"
(ILMN) Two Major Biotech Trends In 2012
by Marc Lichtenfeld, Investment U Senior...
(BMY) Bristol-Myers Squibb Company Kicks Off 2012 Pharma Deals
The spate of acquisitions in the pharma industry continues in 2012 with Bristol-Myers Squibb Company (BMY) announcing the first major deal of the new year. Major merger and acquisition (M&A) deals have...
(INHX) Inhibitex Pipeline Moves Forward – Phase II FV-100 Trial Progressing as Planned
On January 11, 2010, Inhibitex (INHX) announced that the independent Data Safety Monitoring Board (DSMB) met, as scheduled, in early December 2009 to review the 30-day follow-up data on the first quartile...
(INHX) Inhibitex’s Cash Position Now Solid
On November 6, 2009, Inhibitex (INHX) reported financial results for the third quarter period ending September 30, 2009. Total revenues for the quarter were $0.29 million and consisted of $0.25 million in...